Clinical Trials Browser

Phase 2 × Breast Neoplasms × Ramucirumab × Clear all

NCT01234402 2019-08-14

Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients

Phase 2 Completed

153 enrolled 22 charts

Breast Neoplasms

NCT01427933 2017-02-06

A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer

Phase 2 Completed

141 enrolled 15 charts

Breast Neoplasms